PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Human CD34+ progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following LPS challenge.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24558433 ↗2014Reported benefit

Human CD34+ progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following LPS challenge.

MouseEndotoxin/LPSNOD.CB17-Prkdc scid (SCID)Malen = n=4 per group for permeability, myeloperoxidase, neutrophil…Retro-orbital intravenous injection0.2 x 10^6 cells per mouse in 150 microlitres3 hours after lipopolysaccharide challenge

Model: Lipopolysaccharide (Escherichia coli O111:B4) 5 mg/kg body weight by intraperitoneal injection; the survival study used a lethal dose of 11 mg/kg

CD34+ cells reduced lung vascular permeability, myeloperoxidase activity, neutrophil infiltration and pro-inflammatory gene expression, increased endothelial proliferation and improved survival, with 40 per cent surviving at least one week whereas all phosphate-buffered saline and CD34-negative tre…

Extraction: extract · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.